Abstract
Chemotherapy is a main treatment for cancer, and it benefits patients by controlling cancer relapse and metastasis, thereby leading to an increase in the overall survival rate. However, this treatment is associated with mild to severe side effects, one of which is cardiotoxicity. The severity of cardiotoxicity, a leading cause of cardiovascular diseases, depends on the type of cancer therapy employed and the time required for its management. A chemotherapeutic agent is used either alone or in combination with other drugs for cancer treatment. The exact mechanism of chemotherapeutic agent-induced cardiotoxicity remains unclear, although it is likely to be multifactorial and to include oxidative stress, apoptosis, and inflammation. There are many approaches to avoid the untoward effects of chemotherapeutic agents. However, the available options for cardiac protection are minimal, and they include renin-angiotensin system blockers, beta-blockers, herbal drugs, or iron chelators such as dexrazoxane. The present review provides information on the molecular mechanism of chemotherapy-induced myocardial infarction and cardiotoxicity along with scientifically studied synthetic molecules, herbal extracts, and natural products to manage chemotherapy-induced cardiotoxicity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdellatief SA, Galal AA, Farouk SM, Abdel-Daim MM (2017) Ameliorative effect of parsley oil on cisplatin-induced hepato-cardiotoxicity: a biochemical, histopathological, and immunohistochemical study. Biomed Pharmacother 86:482–491. https://doi.org/10.1016/j.biopha.2016.12.038
Abrahams C, Woudberg NJ, Lecour S (2022) Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage? Lipids Health Dis 21(1):1–6. https://doi.org/10.1186/s12944-022-01694-y
Adams VR, Brenner T (1999) Oprelvekin (Neumega), first platelet growth factor for thrombocytopenia. J Am Pharm Assoc (wash) 39:706–707. https://doi.org/10.1016/S1086-5802(15)30363-6
Adıyaman MS, Adıyaman ÖA, Dağlı AF, Karahan MZ, Kaya I, Dağlı MN (2020) Effects of grapeseed extract on doxorubicin-induced cardiotoxicity in rats. Herz 1:6. https://doi.org/10.1007/s00059-019-04888-w
Adıyaman MŞ, Adıyaman ÖA, Dağlı AF, Karahan MZ, Dağlı MN (2022) Prevention of doxorubicin-induced experimental cardiotoxicity by Nigella sativa in rats. Rev Port Cardiol 41(2):99–105. https://doi.org/10.1016/j.repc.2020.12.015
Ahmad N, Wang Y, Ali AK, Ashraf M (2009) Long-acting phosphodiesterase-5 inhibitor, tadalafil, induces sustained cardioprotection against lethal ischemic injury. Am J Physiol Heart Circ Physiol 297:H387–H391. https://doi.org/10.1152/ajpheart.00169.2009
Ahmed AZ, Mumbrekar KD, Satyam SM, Shetty P, D’Souza MR, Singh VK (2021) Chia Seed Oil Ameliorates Doxorubicin-Induced Cardiotoxicity in Female Wistar Rats: An Electrocardiographic. Biochemical and Histopathological Approach Cardiovasc Toxicol 21(7):533–542. https://doi.org/10.1007/s12012-021-09644-3
Ahn HS, Lee DH, Kim TJ, Shin HC, Jeon HK (2017) Cardioprotective effects of a phlorotannin extract against doxorubicin-induced cardiotoxicity in a rat model. J Med Food 20:944–950. https://doi.org/10.1089/jmf.2017.3919
Aktaş I, Özmen Ö, Tutun H, Yalçın A, Türk A (2020) Artemisinin attenuates doxorubicin induced cardiotoxicity and hepatotoxicity in rats. Biotech Histochem 95(2):121–128. https://doi.org/10.1080/10520295.2019.1647457
Alabedi T, Al-Baghdady H, Alahmer M, Bustani G, Al-Dhalimy A (2021) Effects of ocimum tenuiflorum on induced testicular degeneration by filgrastim in Wistar rats. Arch Razi Inst 76:1555–1559. https://doi.org/10.22092/ARI.2021.356079.1772
Al-Rejaie SS, Aleisa AM, Al-Yahya AA, Bakheet SA, Alsheikh A, Fatani AG, Al-Shabanah OA, Sayed-Ahmed MM (2009) Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats. World J Gastroenterol: WJG 15:1373. https://doi.org/10.3748/wjg.15.1373
Alshabanah OA, Hafez MM, Al-Harbi MM, Hassan ZK, Al Rejaie SS, Asiri YA, Sayed-Ahmed MM (2010) Doxorubicin toxicity can be ameliorated during antioxidant L-carnitine supplementation. Oxid Med Cell Longev 3:428–433. https://doi.org/10.4161/oxim.3.6.14416
Amgalan D, Garner TP, Pekson R, Jia XF, Yanamandala M, Paulino V, Liang FG, Corbalan JJ, Lee J, Chen Y (2020) A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy. Nat Cancer 1:315–328. https://doi.org/10.1038/s43018-020-0039-1
Araujo-Gutierrez R, Chitturi KR, Xu J, Wang Y, Kinder E, Senapati A, Chebrolu LB, Kassi M, Trachtenberg BH (2021a) Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity. Cardio-Oncol 7:1–8
Araujo-Gutierrez R, Chitturi KR, Xu J, Wang Y, Kinder E, Senapati A, Chebrolu LB, Kassi M, Trachtenberg BH (2021b) Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity. Cardiooncology 7(1):4. https://doi.org/10.1186/s40959-021-00090-2
Asgharian P, Tazekand AP, Hosseini K, Forouhandeh H, Ghasemnejad T, Ranjbar M, Hasan M, Kumar M, Beirami SM, Tarhriz V, Soofiyani SR (2022) Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. Cancer Cell Int 22(1):1–20. https://doi.org/10.1186/s12935-022-02677-w
Ateyya H, Yosef H, Nader MA (2016) Ameliorative effect of trimetazidine on cisplatin-induced hepatotoxicity in rats. Can J Physiol Pharmacol 94:225–230. https://doi.org/10.1139/cjpp-2015-0304
Bahadır A, Kurucu N, Kadıoğlu M, Yenilme E (2014) The role of nitric oxide in Doxorubicin-induced cardiotoxicity: experimental study. Turk J Haematol 31:68. https://doi.org/10.4274/Tjh.2013.0013
Baniahmad B, Safaeian L, Vaseghi G, Rabbani M, Mohammadi B (2020) Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat. Res Pharm Sci 15:87. https://doi.org/10.4103/1735-5362.278718
Basu A, Penugonda K (2009) Pomegranate juice: a heart-healthy fruit juice. Nutr Rev 67:49–56. https://doi.org/10.1111/j.1753-4887.2008.00133.x
Bayram E, Atalay C, Kocatürk H, Yücel O (2005) Effects of trimetazidine on lipid peroxidation, antioxidant enzyme activities and plasma brain natriuretic peptide levels in patients with chronic cor pulmonale. J Int Med Res 33:612–619. https://doi.org/10.1177/147323000503300602
Bazley L, Gullick WJ (2005) The epidermal growth factor receptor family. Endocr Relat Cancer 12:S17–S27. https://doi.org/10.1677/erc.1.01032
Beiranvand E, Ostad SN, Ardakani EM, Torkashvand F, Sardari S, Vaziri B (2020) In vivo evaluation of carvedilol cardiac protection against trastuzumab cardiotoxicity. Drug Res (stuttg) 70:165–169. https://doi.org/10.1055/a-1110-7034
Belzile-Dugas E, Eisenberg MJ (2021) Radiation-induced cardiovascular disease: review of an underrecognized pathology. J Am Heart Assoc 10:e021686. https://doi.org/10.1161/JAHA.121.021686
Birari L, Wagh S, Patil KR, Mahajan UB, Unger B, Belemkar S, Goyal SN, Ojha S, Patil CR (2020) Aloin alleviates doxorubicin-induced cardiotoxicity in rats by abrogating oxidative stress and pro-inflammatory cytokines. Cancer Chemother Pharmacol 86:419–426. https://doi.org/10.1007/s00280-020-04125-w
Blanca AJ, Ruiz-Armenta MV, Zambrano S, Miguel-Carrasco JL, Arias JL, Arevalo M, Mate A, Aramburu O, Vazquez CM (2016) Inflammatory and fibrotic processes are involved in the cardiotoxic effect of sunitinib: protective role of L-carnitine. Toxicol Lett 241:9–18. https://doi.org/10.1016/j.toxlet.2015.11.007
Block KI, Gyllenhaal C (2005) Commentary: the pharmacological antioxidant amifostine—implications of recent research for integrative cancer care. Integr Cancer Ther 4:329–351. https://doi.org/10.1177/1534735405282842
Boh B, Berovic M, Zhang J, Zhi-Bin L (2007) Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev 13:265–301. https://doi.org/10.1016/S1387-2656(07)13010-6
Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ (2012) A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463–468. https://doi.org/10.1038/nature10777
Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (vol 68, pg 394). CA Cancer J Clin 70:313–313 (2020). https://doi.org/10.3322/caac.21492
Cadeddu Dessalvi C, Deidda M, Noto A, Madeddu C, Cugusi L, Santoro C, López-Fernández T, Galderisi M, Mercuro G (2021) Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity. Antioxid Redox Signal 34:572–588. https://doi.org/10.1089/ars.2020.8055
Cadour F, Thuny F, Sourdon J (2022) New insights in early detection of anticancer drug-related cardiotoxicity using perfusion and metabolic imaging. Front Cardiovasc Med. https://doi.org/10.3389/fcvm.2022.813883
Carll AP, Hazari MS, Perez CM, Krantz QT, King CJ, Winsett DW, Costa DL, Farraj AK (2012) Whole and particle-free diesel exhausts differentially affect cardiac electrophysiology, blood pressure, and autonomic balance in heart failure–prone rats. Toxicol Sci 128:490–499. https://doi.org/10.1093/toxsci/kfs162
Cetik S, Ayhanci A, Sahinturk V (2015) Protective effect of carvacrol against oxidative stress and heart injury in cyclophosphamide-induced cardiotoxicity in rat. Braz Arch Biol Technol 58:569–576. https://doi.org/10.1590/S1516-8913201500022
Checker R, Patwardhan RS, Jayakumar S, Maurya DK, Bandekar M, Sharma D, Sandur SK (2021a) Chemical and biological basis for development of novel radioprotective drugs for cancer therapy. Free Radic Res 55:828–858
Checker R, Patwardhan RS, Jayakumar S, Maurya DK, Bandekar M, Sharma D, Sandur SK (2021b) Chemical and biological basis for development of novel radioprotective drugs for cancer therapy. Free Radic Res 55(5):595–625. https://doi.org/10.1080/10715762.2021.1876854
Chen CT, Wang ZH, Hsu CC, Lin HH, Chen JH (2017) Taiwanese and Japanese yam (Dioscorea spp.) extracts attenuate doxorubicin-induced cardiotoxicity in mice. J Food Drug Anal 25:872–880. https://doi.org/10.1016/j.jfda.2016.09.002
Chen YW, Lee WC, Wu PJ, Fang HY, Fang YN, Chen HC, Tong MS, Sung PH, Lee CH, Chung WJ (2022) Early Levosimendan administration improved weaning success rate in extracorporeal membrane oxygenation in patients with cardiogenic shock. Front Cardiovasc Med. https://doi.org/10.3389/fcvm.2022.912321
Chimenti I, Smith RR, Li TS, Gerstenblith G, Messina E, Giacomello A, Marbán E (2010) Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 106:971–980. https://doi.org/10.1161/CIRCRESAHA.109.210682
Chowdhury S, Sinha K, Banerjee S, Sil PC (2016) Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endoplasmic reticulum stress responses. BioFactors 42:647–664. https://doi.org/10.1002/biof.1301
Cohen MH, Dagher R, Griebel DJ, Ibrahim A, Martin A, Scher NS, Sokol GH, Williams GA, Pazdur R (2002) US Food and Drug Administration drug approval summaries: imatinib mesylate, mesna tablets, and zoledronic acid. Oncologist 7:393–400. https://doi.org/10.1634/theoncologist.7-5-393
Copple IM, Goldring CE, Kitteringham NR, Park BK (2008) The Nrf2–Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicol 246:24–33. https://doi.org/10.1016/j.tox.2007.10.029
Dale DC, Crawford J, Klippel Z, Reiner M, Osslund T, Fan E, Morrow PK, Allcott K, Lyman GH (2018) A systematic literature review of the efficacy, effectiveness, and safety of filgrastim. Support Care Cancer 26:7–20. https://doi.org/10.1007/s00520-017-3854-x
Deng S, Yan T, Jendrny C, Nemecek A, Vincetic M, Gödtel-Armbrust U, Wojnowski L (2014) Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both topoisomerase II isoforms. BMC Cancer 14:1–11. https://doi.org/10.1186/1471-2407-14-842
Dicarlo AL, Horta ZP, Aldrich JT, Jakubowski AA, Skinner WK, Case CM Jr (2019) Use of growth factors and other cytokines for treatment of injuries during a radiation public health emergency. Radiat Res 192:99–120. https://doi.org/10.1667/RR15363.1
Dos Santos JM, Alfredo TM, Antunes KÁ, Da Cunha JDSM, Costa EMA, Lima ES, Silva DB, Carollo CA, Schmitz WO, Boleti APDA (2018) Guazuma ulmifolia Lam. decreases oxidative stress in blood cells and prevents doxorubicin-induced cardiotoxicity. Oxid Med Cell Longev 2018:2935051. https://doi.org/10.1155/2018/2935051
Dos Santos JM, Alfredo TM, Antunes KÁ, da Cunha JDSM, Costa EMA, Lima ES, Silva DB, Carollo CA, Schmitz WO, Boleti APA, Dos Santos EL, de Picoli SK (2018) Guazuma ulmifolia Lam. decreases oxidative stress in blood cells and prevents doxorubicin-induced cardiotoxicity. Oxid Med Cell Longev 2018:2935051. https://doi.org/10.1155/2018/2935051
Drummond GR, Cai H, Davis ME, Ramasamy S, Harrison DG (2000) Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 86:347–354. https://doi.org/10.1161/01.res.86.3.347
Dubocovich ML (1995) Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 16:50–56. https://doi.org/10.1016/s0165-6147(00)88978-6
Efentakis P, Varela A, Chavdoula E, Sigala F, Sanoudou D, Tenta R, Gioti K, Kostomitsopoulos N, Papapetropoulos A, Tasouli A, Farmakis D, Davos CH, Klinakis A, Suter T, Cokkinos DV, Iliodromitis EK, Wenzel P, Andreadou I (2020) Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy. Cardiovasc Res 116(3):576–591. https://doi.org/10.1093/cvr/cvz163
Eisvand F, Imenshahidi M, Ghasemzadeh Rahbardar M, Tabatabaei Yazdi SA, Rameshrad M, Razavi BM, Hosseinzadeh H (2022) Cardioprotective effects of alpha-mangostin on doxorubicin-induced cardiotoxicity in rats. Phytother Res 36(1):506–524. https://doi.org/10.1002/ptr.7356
Ekinci Akdemir FN, Yildirim S, Kandemir FM, Tanyeli A, Küçükler S, Bahaeddin Dortbudak M (2021) Protective effects of gallic acid on doxorubicin-induced cardiotoxicity; an experimantal study. Arch Physiol Biochem 127(3):258–265. https://doi.org/10.1080/13813455.2019.1630652
El-Hawwary AA, Omar NM (2019) The influence of ginger administration on cisplatin-induced cardiotoxicity in rat: Light and electron microscopic study. Acta Histochem 121:553–562. https://doi.org/10.1016/j.acthis.2019.04.013
Elrashidy RA, Hasan RA (2021) Cilostazol preconditioning alleviates cyclophosphamide-induced cardiotoxicity in male rats: mechanistic insights into SIRT1 signaling pathway. Life Sci 266:118822. https://doi.org/10.1016/j.lfs.2020.118822
El-Sawalhi MM, Ahmed LA (2014) Exploring the protective role of apocynin, a specific NADPH oxidase inhibitor, in cisplatin-induced cardiotoxicity in rats. Chem Biol Interact 207:58–66. https://doi.org/10.1016/j.cbi.2013.11.008
Erboga M, Donmez YB, Sener U, Erboga ZF, Aktas C, Kanter M (2016) Effect of urtica dioica against doxorubicin-induced cardiotoxicity in rats through suppression of histological damage, oxidative stress and lipid peroxidation. Eur J Gen Med. https://doi.org/10.15197/ejgm.1567
Erdogmus Ozgen Z, Erdinc M, Kelle İ, Erdinc L, Nergiz Y (2022) Protective effects of necrostatin-1 on doxorubicin-induced cardiotoxicity in rat heart. Hum Exp Toxicol 41:09603271211066066. https://doi.org/10.1177/09603271211066066
Feng Y, Chao W (2011) Toll-like receptors and myocardial inflammation. Int J Inflam. https://doi.org/10.4061/2011/170352
Feola M, Garrone O, Occelli M, Francini A, Biggi A, Visconti G, Albrile F, Bobbio M, Merlano M (2011) Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide. Int J Cardiol 148:194–198. https://doi.org/10.1016/j.ijcard.2009.09.564
Fikriansyah F, Widiastuti M, Wulandari N, Tirtanirmala P, Murwanti R (2015) Cardioprotective effect of Kelor (Moringa oleifera) leaf ethanolic extract against doxorubicin-induced cardiotoxicity in rats. ISCC 6:53–57. https://doi.org/10.14499/indonesianjcanchemoprev6iss2pp53-57
García-Pastor C, de Llano JPNG, Balcázar-Padrón JC, Tristán-López L, Rios C, Díaz-Ruíz A, Nathal E (2022) Neuroprotective effect of dapsone in patients with aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled clinical trial. Neurosurg Focus 52(3):E12. https://doi.org/10.3171/2021.12.FOCUS21663
Gazia MA, El-Magd MA (2018) Ameliorative effect of cardamom aqueous extract on doxorubicin-induced cardiotoxicity in rats. Cells Tissues Organs 206:62–72. https://doi.org/10.1159/000496109
Hamza AA, Ahmed MM, Elwey HM, Amin A (2016) Melissa officinalis protects against doxorubicin-induced cardiotoxicity in rats and potentiates its anticancer activity on MCF-7 cells. PLoS ONE 11:e0167049. https://doi.org/10.1371/journal.pone.0167049
Hassanpour Fard M, Ghule AE, Bodhankar SL, Dikshit M (2011) Cardioprotective effect of whole fruit extract of pomegranate on doxorubicin-induced toxicity in rat. Pharm Biol 49:377–382. https://doi.org/10.3109/13880209.2010.517758
He H, Wang L, Qiao Y, Yang B, Yin D, He M (2021) Epigallocatechin-3-gallate pretreatment alleviates doxorubicin-induced ferroptosis and cardiotoxicity by upregulating AMPKα2 and activating adaptive autophagy. Redox Biol 48:102185. https://doi.org/10.1016/j.redox.2021.102185
Hekmat AS, Navabi Z, Alipanah H, Javanmardi K (2021) Alamandine significantly reduces doxorubicin-induced cardiotoxicity in rats. Hum Exp Toxicol 40(10):1781–1795. https://doi.org/10.1177/09603271211010896
Herrmann J (2020) Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. Nat Rev Cardiol 17:474–502. https://doi.org/10.1038/s41569-020-0348-1
Hu X, Li C, Wang Q, Wei Z, Chen T, Wang Y, Li Y (2022) Dimethyl fumarate ameliorates doxorubicin-induced cardiotoxicity by activating the Nrf2 Pathway. Front Pharmacol. https://doi.org/10.3389/fphar.2022.872057
Huang MF, Pang LK, Chen YH, Zhao R, Lee DF (2021) Cardiotoxicity of antineoplastic therapies and applications of induced pluripotent stem cell-derived cardiomyocytes. Cells 10(11):2823. https://doi.org/10.3390/cells10112823
Hung YC, Wang PW, Lin TY, Yang PM, You JS, Pan TL (2020) Functional redox proteomics reveal that Salvia miltiorrhiza aqueous extract alleviates adriamycin-induced cardiomyopathy via inhibiting ROS-dependent apoptosis. Oxid Med Cell Longev 2020:5136934. https://doi.org/10.1155/2020/5136934
Hussein A, Ahmed AA, Shouman SA, Sharawy S (2012) Ameliorating effect of DL-α-lipoic acid against cisplatin-induced nephrotoxicity and cardiotoxicity in experimental animals. Drug Discov Ther 6:147–156. https://doi.org/10.5582/ddt.2012.v6.3.147
Ibrahim DM, Radwan RR, Fattah SMA (2017) Antioxidant and antiapoptotic effects of sea cucumber and valsartan against doxorubicin-induced cardiotoxicity in rats: the role of low dose gamma irradiation. J Photochem Photobiol B 170:70–78. https://doi.org/10.1016/j.jphotobiol.2017.03.022
Ikewuchi JC, Ikewuchi CC, Ifeanacho MO, Jaja VS, Okezue EC, Jamabo CN, Adeku KA (2021) Attenuation of doxorubicin-induced cardiotoxicity in Wistar rats by aqueous leaf-extracts of Chromolaena odorata and Tridax procumbens. J Ethnopharmacol 274:114004. https://doi.org/10.1016/j.jep.2021.114004
JaN S, Hewawasam RP, KaPW J, Mudduwa LKB (2021) Cinnamomum zeylanicum Blume (Ceylon cinnamon) bark extract attenuates doxorubicin induced cardiotoxicity in Wistar rats. Saudi Pharm J 29:820–832. https://doi.org/10.1016/j.jsps.2021.06.004
Jones IC, Dass CR (2022) Doxorubicin-induced cardiotoxicity: causative factors and possible interventions. J Pharm Pharmacol 22:rgac063. https://doi.org/10.1093/jpp/rgac063
Jones IC, Dass CR (2022) Doxorubicin-induced cardiotoxicity: causative factors and possible interventions. J Pharm Pharmacol. https://doi.org/10.1093/jpp/rgac063
Junior JTC, De Morais SM, Gomez CV, Molas CC, Rolon M, Boligon AA, Athayde ML, De Morais Oliveira CD, Tintino SR, Douglas MCH (2016) Phenolic composition and antiparasitic activity of plants from the Brazilian Northeast “Cerrado.” Saudi J Biol Sci 23:434–440. https://doi.org/10.1016/j.sjbs.2015.10.009
Kanno S, Wu YJL, Lee PC, Billiar TR, Ho C (2001) Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats. Circulation 104:945–950. https://doi.org/10.1161/hc3401.093155
Karale S, Kamath JV (2016) Cardioprotective effect of Mentha longifolia against cyclophosphamide-induced cardiotoxicity in rats: a biochemical, electrocardiographic and histopathological study. Int J Pharm Pharm Sci 8(9):214–217. https://doi.org/10.22159/ijpps.2016v8i9.13004
Karar J, Maity A (2011) PI3K/AKT/mTOR pathway in angiogenesis. Front Mol Neurosci 4:51. https://doi.org/10.3389/fnmol.2011.00051
Karunasree C, Prasad P, Reddy VJ, Madakka M (2015) Cardioprotective effect of Scleria lithosperma on doxorubicin-induced cardiotoxicity in Wistar albino rats. Ann Res Rev Biol 1:9. https://doi.org/10.9734/ARRB/2015/11369
KG, CP (2019) Euterpe oleracea Mart.(Açai) supplementation attenuates acute doxorubicin-induced cardiotoxicity in rats. Cell Physiol Biochem 53:388–399. https://doi.org/10.33594/000000145
Khajavi Rad A, Entezari Heravi N, Kamkar-Del Y, Abbasnezhad A, Jalili-Nik M, Shafei MN, Mohebbati R (2021) A standardized extract of Ziziphus jujuba Mill protects against adriamycin-induced liver, heart, and brain toxicity: an oxidative stress and biochemical approach. J Food Biochem 45(4):e13698. https://doi.org/10.1111/jfbc.13698
Khan G, Haque SE, Anwer T, Ahsan MN, Safhi MM, Alam M (2014) Cardioprotective effect of green tea extract on doxorubicin-induced cardiotoxicity in rats. Acta Pol Pharm 71:861–868
Khazdooz H, Nourian M, Jalaeikhoo H, Rajaeinejad M, Johari Moghadam A, Iranpour M, Naghoosi H, Tofangchiha S (2019) The effect of N-Aacetylcysteine administration to prevent anthracycline-induced cardiotoxicity in breast cancer patients. Multidisciplin Cancer Invest 3:16–19. https://doi.org/10.30699/acadpub.mci.3.3.16
Koka S, Kukreja RC (2010) Attenuation of doxorubicin-induced cardiotoxicity by tadalafil: a long acting phosphodiesterase-5 inhibitor. Mol Cell Pharmacol 2:173–178
Koka S, Das A, Zhu SG, Durrant D, Xi L, Kukreja RC (2010) Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect. J Pharmacol Exp Therap 334:1023–1030. https://doi.org/10.1124/jpet.110.170191
Kubota S, Hara H, Hiroi Y (2021) Current status and future perspectives of onco-cardiology: Importance of early detection and intervention for cardiotoxicity, and cardiovascular complication of novel cancer treatment. Glob Health Med 3(4):214–225. https://doi.org/10.35772/ghm.2021.01024
Langer SW (2014) Dexrazoxane for the treatment of chemotherapy-related side effects. Cancer Manag Res 6:357–363. https://doi.org/10.2147/CMAR.S47238
Legi A, Rodriguez E, Eckols TK, Mistry C, Robinson P (2021) Substance P antagonism prevents chemotherapy-induced cardiotoxicity. Cancer 13:1732. https://doi.org/10.3390/cancers13071732
Li D, Liu X, Pi W, Zhang Y, Yu L, Xu C, Sun Z, Jiang J (2021) Fisetin attenuates doxorubicin-induced cardiomyopathy in vivo and in vitro by inhibiting ferroptosis through sirt1/nrf2 signaling pathway activation. Front Pharmacol 12:808480–808480. https://doi.org/10.3389/fphar.2021.808480
Li W, Wang X, Liu T, Zhang Q, Cao J, Jiang Y, Sun Q, Li C, Wang W, Wang Y (2022) Harpagoside protects against doxorubicin-induced cardiotoxicity via P53-Parkin-mediated mitophagy. Front Cell Dev Biol. https://doi.org/10.3389/fcell.2022.813370
Lin H, Meng L, Sun Z, Sun S, Huang X, Lin N, Zhang J, Lu W, Yang Q, Chi J, Guo H (2021) Yellow wine polyphenolic compound protects against doxorubicin-induced cardiotoxicity by modulating the composition and metabolic function of the gut microbiota. Circ Heart Fail 14(10):e008220. https://doi.org/10.1161/CIRCHEARTFAILURE.120.008220
Liu X, Chen Z, Chua CC, Ma YS, Youngberg GA, Hamdy R, Chua BH (2002) Melatonin as an effective protector against doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol 283(1):H254–H263. https://doi.org/10.1152/ajpheart.01023.2001
Liu Y, Tan D, Shi L, Liu X, Zhang Y, Tong C, Song D, Hou M (2015) Blueberry anthocyanins-enriched extracts attenuate cyclophosphamide-induced cardiac injury. PLoS ONE 10:e0127813. https://doi.org/10.1371/journal.pone.0127813
Liu G, Zhang J, Sun F, Ma J, Qi X (2022a) Ginsenoside Rg2 attenuated trastuzumab-induced cardiotoxicity in rats. Biomed Res Int 2022:8866660. https://doi.org/10.1155/2022/8866660
Liu X, Qiu Y, Huang N, Liu YH, Wang HH, Yu YN, Song YT, Wan GR, Wang SX, Li P, Yin YL (2022b) Citronellal alleviates doxorubicin-induced cardiotoxicity by suppressing oxidative stress and apoptosis via Na+/H+ exchanger-1 inhibition. J Biochem Mol Toxicol 36(3):22971. https://doi.org/10.1002/jbt.22971
Lu J, He R, Sun P, Zhang F, Linhardt RJ, Zhang A (2020) Molecular mechanisms of bioactive polysaccharides from Ganoderma lucidum (Lingzhi), a review. Int Biol Macromol 150:765–774. https://doi.org/10.1016/j.ijbiomac.2020.02.035
Lv SY, He S, Ling XL, Wang YQ, Huang C, Long JR, Wang JQ, Qin Y, Wei H, Yu CY (2022) Review of lipoic acid: from a clinical therapeutic agent to various emerging biomaterials. Int J Pharm 627:122201. https://doi.org/10.1016/j.ijpharm.2022.122201
Lyu YL, Kerrigan JE, Lin CP, Azarova AM, Tsai YC, Ban Y, Liu LF (2007) Topoisomerase IIβ–mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res 67:8839–8846. https://doi.org/10.1158/0008-5472.CAN-07-1649
Mahajan J, Mohan M (2016) Protective effect of n-butanol extract of Nyctanthes arbortristis on antioxidant tissue defence system against doxurubicin induced cardiotoxicity in rats. J Integr Health Sci 4:9–17. https://doi.org/10.4103/2347-6486.240047
Malarkodi K, Sivaprasad R, Varalakshmi P (2004) Effect of lipoic acid on the oxidoreductive status of red blood cells in rats subject to oxidative stress by chronic administration of adriamycin. Hum Exp Toxicol 23:129–135. https://doi.org/10.1191/0960327104ht428oa
Mansour HH, Hasan HF (2015) Protective effect of N-acetylcysteine on cyclophosphamide-induced cardiotoxicity in rats. Env Toxicol Pharmacol 40:417–422. https://doi.org/10.1016/j.etap.2015.07.013
Maqsood H, Ashraf T, Younus S, Rasool M, Hameed A (2022a) Pharmacological evaluation of the use of dexrazoxane in preventing anthracycline induced cardiotoxicity in breast cancer. Euro Heart J 43:ehab849.171. https://doi.org/10.1093/eurheartj/ehab849.171
Maqsood H, Ashraf T, Younus S, Rasool MW, Hameed A (2022b) Pharmacological evaluation of the use of dexrazoxane in preventing anthracycline induced cardiotoxicity in breast cancer. Eur Heart J 43:849–171. https://doi.org/10.1093/eurheartj/ehab849.171
Mathew AA, Asirvatham R, Dawn VT (2021) Cardioprotective effect of marsdenia tenacissima and sansevieria roxburghiana in doxorubicin-induced cardiotoxicity in rats in vivo: the role of dresgenin and lupeol. Turkish J Pharm Sci 18:271. https://doi.org/10.4274/tjps.galenos.2020.27880
Mathias LMBS, Alegre PHC, Dos Santos IOF, Bachiega T, Figueiredo AM, Chiuso-Minicucci F, Fernandes AA, Bazan SGZ, Minicucci MF, Azevedo PS, Okoshi MP, Zornoff LAM, Paiva SAR, Polegato BF (2019) Euterpe oleracea Mart. (Açai) supplementation attenuates acute doxorubicin-induced cardiotoxicity in rats. Cell Physiol Biochem 53(2):388–399. https://doi.org/10.33594/000000145
Mccormack K (2018) The cardioprotective effect of dexrazoxane (Cardioxane) is consistent with sequestration of poly (ADP-ribose) by self-assembly and not depletion of topoisomerase 2B. Cancer Med Sci. https://doi.org/10.3332/ecancer.2018.889
Meeran MN, Azimullah S, Mamoudh HH, Sharma C, Kumar S, Goyal SN, Ojha S (2021) Nerolidol, a sesquiterpene from the essential oils of aromatic plants, attenuates doxorubicin-induced chronic cardiotoxicity in rats. J Agri Food Chem 69:7334–7343. https://doi.org/10.1021/acs.jafc.0c05667
Mencherini T, Picerno P, Scesa C, Aquino R (2007) Triterpene, antioxidant, and antimicrobial compounds from Melissa officinalis. J Natur Product 70:1889–1894. https://doi.org/10.1021/np070351s
Merwid-Ląd A, Ziółkowski P, Szandruk-Bender M, Matuszewska A, Szeląg A, Trocha M (2021) Effect of a low dose of carvedilol on cyclophosphamide-induced urinary toxicity in rats-a comparison with mesna. Pharmaceutical 14:1237. https://doi.org/10.3390/ph14121237
Milano G, Biemmi V, Lazzarini E, Balbi C, Ciullo A, Bolis S, Ameri P, Di Silvestre D, Mauri P, Barile L (2020) Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity. Cardiovas Res 116:383–392. https://doi.org/10.1093/cvr/cvz108
Miller KD, Fidler-Benaoudia M, Keegan TH, Hipp HS, Jemal A, Siegel RL (2020) Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clini 70:443–459. https://doi.org/10.3322/caac.21637
Mohamad RH, El-Bastawesy AM, Zekry ZK, Al-Mehdar HA, Al-Said MGaM, Aly SS, Sharawy SM, El-Merzabani MM (2009) The role of Curcuma longa against doxorubicin (adriamycin)-induced toxicity in rats. J Med Food 12:394–402. https://doi.org/10.1089/jmf.2007.0715
Mohamadian M, Parsamanesh N, Chiti H, Sathyapalan T, Sahebkar A (2022) Protective effects of curcumin on ischemia/reperfusion injury. Phytotherap Res. https://doi.org/10.1002/ptr.7620
Mohamed ET, Safwat GM (2016) Evaluation of cardioprotective activity of Lepidium sativum seed powder in albino rats treated with 5-fluorouracil. Beni-Suef Univ J Basic Appl Sci 5(2):208–215. https://doi.org/10.1016/j.bjbas.2016.05.001
Moi P, Chan K, Asunis I, Cao A, Kan YW (1994) Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Nat Acad Sci USA 91:9926–9930. https://doi.org/10.1073/pnas.91.21.9926
Mori H, Nakamachi T, Ohtaki H, Yofu S, Sato A, Endo K, Iso Y, Suzuki H, Takeyama Y, Shintani N (2010) Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on doxorubicin-induced cardiomyopathy in mice. Circ J. https://doi.org/10.1253/circj.cj-09-1024
Moura LR, Orpinelli SRT, Sugita DM, Pinheiro G, Faleiro MBR, Conceição ECD, Moura V (2018) Effect of the ethanolic extract of pequi (Caryocar brasiliense) peel on acute cardiotoxicity induced by doxorubicin in Wistar rats (Rattus norvegicus albinus). Semina Ciências Agrárias 39:1981–1992. https://doi.org/10.5433/1679-0359.2018v39n5p1981
Mu W, Chu Q, Liu Y, Zhang N (2020) A review on nano-based drug delivery system for cancer chemoimmunotherapy. Nano-Micro Lett 12:1–24. https://doi.org/10.1007/s40820-020-00482-6
Mubarak S, Hamid SA, Farrag AR, Samir N, Hussein JS (2018) Cardioprotective effect of date palm against doxorubicin-induced cardiotoxicity. Asian J Pharm Clin Res 11:141–146. https://doi.org/10.22159/ajpcr.2018.v11i7.24453
Mukhopadhyay P, Rajesh M, BáTkai S, Haskó GR, Szabo C, Liaudet L, Pacher P (2007) Role of superoxide, nitric oxide and peroxynitrite in doxorubicin-induced cell death in vitro and in vivo. Am Heart Assoc. https://doi.org/10.1152/ajpheart.00795.2008
Mythili Y, Sudharsan P, Varalakshmi P (2005) Cytoprotective role of DL-α-Lipoic acid in cyclophosphamide induced myocardial toxicity. Mole Cell Biochem 276:39–44. https://doi.org/10.1007/s11010-005-2735-7
Nagi MN, Al-Shabanah OA, Hafez MM, Sayed-Ahmed MM (2011) Thymoquinone supplementation attenuates cyclophosphamide-induced cardiotoxicity in rats. J Biochem Mole Toxicol 25:135–142. https://doi.org/10.1002/jbt.20369
Nozaki N, Shishido T, Takeishi Y, Kubota I (2004) Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2–knockout mice. Circulation 110:2869–2874. https://doi.org/10.1161/01.CIR.0000146889.46519.27
Numan IT, Hamad MN, Fadhil AA, Najim SM (2016) The possible cardio-protective effects of ethanolic artichoke extract against 5-fluorouracil induced cardiac toxicity in rats. Iraqi J Pharm Sci (P-ISSN: 1683-3597, E-ISSN: 2521-3512) 25:1-5. https://doi.org/10.31351/vol25iss1pp1-5
Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL (2012) Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mole Cell Cardiol 52:1213–1225. https://doi.org/10.1016/j.yjmcc.2012.03.006
Oliveira PJ, Bjork JA, Santos MS, Leino RL, Froberg MK, Moreno AJ, Wallace KB (2004) Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity. Toxicol App Pharmacol 200:159–168. https://doi.org/10.1016/j.taap.2004.04.005
Olorundare OE, Adeneye AA, Akinsola AO, Sanni DA, Koketsu M, Mukhtar H (2020) Clerodendrum volubile ethanol leaf extract: a potential antidote to doxorubicin-induced cardiotoxicity in rats. J Toxicol. https://doi.org/10.1155/2020/8859716
Perakakis N, Triantafyllou GA, Fernández-Real JM, Huh JY, Park KH, Seufert J, Mantzoros CS (2017) Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol 13:324–337. https://doi.org/10.1038/nrendo.2016.221
Prahalathan C, Selvakumar E, Varalakshmi P, Kumarasamy P, Saravanan R (2006) Salubrious effects of lipoic acid against adriamycin-induced clastogenesis and apoptosis in Wistar rat bone marrow cells. Toxicol 222:225–232. https://doi.org/10.1016/j.tox.2006.02.015
Qi W, Boliang W, Xiaoxi T, Guoqiang F, Jianbo X, Gang W (2020) Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling. Biomed Pharmacother 122:109547. https://doi.org/10.1016/j.biopha.2019.109547
Radtke ML, Kolesar JM (2005) Palifermin (Kepivance™) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support. J Oncol Pharm Pract 11:121–125. https://doi.org/10.1191/1078155205jp159oa
Rahbardar MG, Eisvand F, Rameshrad M, Razavi BM, Hosseinzadeh H (2022) In vivo and in vitro protective effects of rosmarinic acid against doxorubicin-induced cardiotoxicity. Nutr Cancer 74:747–760. https://doi.org/10.1080/01635581.2021.1931362
Rallis KS, Yau THL, Sideris M (2021) Chemoradiotherapy in cancer treatment: rationale and clinical applications. Anticancer Res 41:1–7. https://doi.org/10.21873/anticanres.14746
Ramin C, Schaeffer ML, Zheng Z, Connor AE, Hoffman-Bolton J, Lau B, Visvanathan K (2021) All-cause and cardiovascular disease mortality among breast cancer survivors in CLUE II, a long-standing community-based cohort. JNCI 113(2):137–145. https://doi.org/10.1093/jnci/djaa096
Rao VU, Reeves DJ, Chugh AR, O’quinn R, Fradley MG, Raghavendra M, Dent S, Barac A, Lenihan D (2021) Clinical approach to cardiovascular toxicity of oral antineoplastic agents: JACC state-of-the-art review. J Am Coll Cardiol 77:2693–2716. https://doi.org/10.1016/j.jacc.2021.04.009
Rašković A, Stilinović N, Kolarović J, Vasović V, Vukmirović S, Mikov M (2011) The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. Molecules 16:8601–8613. https://doi.org/10.3390/molecules16108601
Rawat PS, Jaiswal A, Khurana A, Bhatti JS, Navik U (2021) Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management. Biomed Pharmacother 139:111708. https://doi.org/10.1016/j.biopha.2021.111708
Raynaud F, Mauviard F, Geoffriau M, Claustrat B, Pevet P (1993) Plasma 6-hydroxymelatonin, 6-sulfatoxymelatonin and melatonin kinetics after melatonin administration to rats. Neurosignal 2:359–366. https://doi.org/10.1159/000109516
Razmaraii N, Babaei H, Nayebi AM, Assadnassab G, Helan JA, Azarmi Y (2016) Cardioprotective effect of grape seed extract on chronic doxorubicin-induced cardiac toxicity in Wistar rats. Adv Pharm Bull 6:423–433. https://doi.org/10.15171/apb.2016.055
Refaie MM, Abdel-Gaber SA, Abd El Rahman SA, Hafez SMNA, Khalaf HM (2022) Cardioprotective effects of bosentan in 5-fluorouracil-induced cardiotoxicity. Toxicology 465:153042. https://doi.org/10.1016/j.tox.2021.153042
Sadeghi S, Kalhor H, Panahi M, Abolhasani H, Rahimi B, Kalhor R, Mehrabi A, Vahdatinia M, Rahimi H (2021) Keratinocyte growth factor in focus: a comprehensive review from structural and functional aspects to therapeutic applications of palifermin. Int J Biol Macromole 191:1175–1190. https://doi.org/10.1016/j.ijbiomac.2021.09.151
Safarpour S, Pirzadeh M, Ebrahimpour A, Shirafkan F, Madani F, Hosseini M, Moghadamnia AA, Kazemi S (2022a) Protective effect of kaempferol and its nanoparticles on 5-fluorouracil-induced cardiotoxicity in rats. BioMed Res Int. https://doi.org/10.1155/2022/2273000
Safarpour S, Safarpour S, Pirzadeh M, Moghadamnia AA, Ebrahimpour A, Shirafkan F, Mansoori R, Kazemi S, Hosseini M (2022b) Colchicine ameliorates 5-Fluorouracil-induced cardiotoxicity in rats. Oxid Med Cell Longev. https://doi.org/10.1155/2022/6194532
Safdar MN, Kausar T, Nadeem M, Jabbar S, Ahmed S, Taj T, Tufail F, Mehmood W (2017) Cardioprotective effect of mango and kinnow peel extracts on doxorubicin-induced cardiotoxicity in Albino Rats”. Proc Pak Acad Sci Pak Acad Sci B 54:219–235
Saleh Ahmed AS (2022) Potential protective effect of catechin on doxorubicin-induced cardiotoxicity in adult male albino rats. Toxicol Mech Methods 32(2):97–105. https://doi.org/10.1080/15376516.2021.1972375
Sandamali JA, Hewawasam RP, Jayatilaka KA, Mudduwa LK (2020) Cardioprotective potential of Murraya koenigii (L.) Spreng. leaf extract against doxorubicin-induced cardiotoxicity in rats. Evid Based Complement Altern Med. https://doi.org/10.1155/2020/6023737
Sapkota Y, Liu Q, Li N, Bhatt NS, Ehrhardt MJ, Wilson CL, Yasui Y (2022) Contribution of genome-wide polygenic score to risk of coronary artery disease in childhood cancer survivors. Cardio Oncol 4(2):258–267
Sekeroğlu V, Aydin B, Sekeroğlu ZA (2011) Viscum album L. extract and quercetin reduce cyclophosphamide-induced cardiotoxicity, urotoxicity and genotoxicity in mice. Asian Pac J Cancer Prev 12(11):2925–2931. https://doi.org/10.1016/j.mrgentox.2012.02.012
Shahidullah M, Janarthan M, Khan MS (2017) Evaluation of cardioprotective activity of maceration extract of Elettaria cardamomum in doxorubicin-induced cardiotoxicity in rats. Ind J Res Pharm Biotechnol 5:366–370
Sheibani M, Nezamoleslami S, Faghir-Ghanesefat H, Emami AH, Dehpour AR (2020) Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats. Cancer Chemother Pharmacol 85(3):563–571. https://doi.org/10.1007/s00280-019-04019-6
Sheibani M, Azizi Y, Shayan M, Nezamoleslami S, Eslami F, Farjoo MH, Dehpour AR (2022) Doxorubicin-induced cardiotoxicity: an overview on pre-clinical therapeutic approaches. Cardiovasc Toxicol. https://doi.org/10.1007/s12012-022-09721-1
Shouman SA, Noimi FM, Gashlan HM (2006) Evaluation of the potential protective effect of captopril against doxorubicin-induced cardiotoxicity in rats. J Egypt Soc Toxicol 35:123–129
Sihotang Y, Silalahi J, Anjelisa P (2016) Cardioprotective effect of Ethylacetate extract of Zanthoxylum acanthopodium Dc. against doxorubicin-induced cardiotoxicity in Rats. Int J PharmTech Res 9:249–253
Sikandar A, Farhat K, Afzal A, Ajmal K, Laeeq M, Khokhar A (2020) Protective effects of trimetazidine against doxorubicin-induced cardiotoxicity and hepatotoxicity in mice. J Ayub Med Coll Abbottabad 32:304–309
Singh MP, Panda H (2005) Medicinal herbs with their formulations. Daya Book, Delhi, pp 97–408
Singh G, Singh AT, Abraham A, Bhat B, Mukherjee A, Verma R, Agarwal SK, Jha S, Mukherjee R, Burman AC (2008) Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity. J Ethnopharmacol 117:123–129. https://doi.org/10.1016/j.jep.2008.01.022
Singh M, Nicol AT, DelPozzo J, Wei J, Singh M, Nguyen T, Kobayashi S, Liang Q (2022) Demystifying the relationship between metformin, AMPK, and doxorubicin cardiotoxicity. Front Cardiovasc Med. https://doi.org/10.3389/fcvm.2022.839644
Sirwi A, Shaik RA, Alamoudi AJ, Eid BG, Elfaky MA, Ibrahim SR, Mohamed GA, Abdallah HM, Abdel-Naim AB (2022) Mokko lactone alleviates doxorubicin-induced cardiotoxicity in rats via antioxidant, anti-inflammatory, and antiapoptotic activities. Nutrients 14(4):733. https://doi.org/10.3390/nu14040733
Soucek P, Kondrová E, Hermanek J, Stopka P, Boumendjel A, Ueng YF, Gut I (2011) New model system for testing effects of flavonoids on doxorubicin-related formation of hydroxyl radicals. Anti-Cancer Drug 22:176–184. https://doi.org/10.1097/cad.0b013e328341a17b
Souto CGRG, Lorençone BR, AaM Marques, RaC Palozi, Romão PVM, Guarnier LP, CaS Tirloni, Dos Santos AC, Souza RIC, Zago PMJJ (2021) Cardioprotective effects of Talinum paniculatum (Jacq.) Gaertn in doxorubicin-induced cardiotoxicity in hypertensive rats. J Ethnopharmacol 281:114568. https://doi.org/10.1016/j.jep.2021.114568
Subramaniam V, Chuang G, Xia H, Burn B, Bradley J, Maderdrut JL, Coy DH, Varner KJ (2017) Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice. Peptide 95:25–32. https://doi.org/10.1016/j.peptides.2017.07.007
Sudarsan VM, Sudheer A, Krishna KR, Swathi K, Sarvasree P, Ashwini M (2019) Evaluation of cardioprotective effect of ethanolic extract of on Abelmoshcus esculentus doxorubicin induced cardiotoxicity in rats. Asian J Pharm Pharmacol 5:755–761. https://doi.org/10.31024/ajpp.2019.5.4.15
Sun J, Sun G, Meng X, Wang H, Luo Y, Qin M, Ma B, Wang M, Cai D, Guo P (2013) Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. PLoS ONE 8:e64526. https://doi.org/10.1371/journal.pone.0064526
Sun Z, Lu W, Lin N, Lin H, Zhang J, Ni T, Meng L, Zhang C, Guo H (2020) Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1. Biochem Pharmacol 175:113888. https://doi.org/10.1016/j.bcp.2020.113888
Sun X, Sun P, Zhen D, Xu X, Yang L, Fu D, Wei C, Niu X, Tian J, Li H (2022) Melatonin alleviates doxorubicin-induced mitochondrial oxidative damage and ferroptosis in cardiomyocytes by regulating YAP expression. Toxicol Appl Pharmacol 437:115902. https://doi.org/10.1016/j.taap.2022.115902
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660
Svanberg A, Birgegård G (2015) Addition of aprepitant (Emend®) to standard antiemetic regimen continued for 7 days after chemotherapy for stem cell transplantation provides significant reduction of vomiting. Oncology 89:31–36. https://doi.org/10.1159/000371523
Swamy AV, Patel U, Koti B, Gadad P, Patel N, Thippeswamy A (2013) Cardioprotective effect of Saraca indica against cyclophosphamide-induced cardiotoxicity in rats: a biochemical, electrocardiographic and histopathological study. Indian J Pharmacol 45:44. https://doi.org/10.4103/0253-7613.106434
Syukri A, Hatta M, Amir M, Rohman MS, Mappangara I, Kaelan C, Febrianti A (2022) Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage. Ann Med Surg. https://doi.org/10.1016/j.amsu.2022.103501
Talalay P, Dinkova-Kostova AT, Holtzclaw WD (2003) Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv Enzyme Regul 43:121–134. https://doi.org/10.1016/s0065-2571(02)00038-9
Tian W, Yang L, Liu Y, He J, Yang L, Zhang Q, Liu F, Li J, Liu J, Sumi S, Shen Y, Qi Z (2020) Resveratrol attenuates doxorubicin-induced cardiotoxicity in rats by up-regulation of vascular endothelial growth factor B. J Nutr Biochem 79:108132. https://doi.org/10.1016/j.jnutbio.2019.01.018
Tipoe GL, Leung TM, Hung MW, Fung ML (2007) Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets 7:135–144. https://doi.org/10.2174/187152907780830905
Unger JM, Vaidya R, Albain KS, LeBlanc M, Minasian LM, Gotay CC, Henry NL, Fisch MJ, Lee SM, Blanke CD, Hershman DL (2022) Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials. J Clin Oncol 40(13):1474–1486. https://doi.org/10.1200/JCO.21.02377
Van Dalen EC, Caron HN, Dickinson HO, Kremer LC (2011) Cardioprotective interventions for cancer patients receiving anthracyclines. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003917.pub4
Varadharajan R, Rajalingam D, Palani S (2016) GCMS/MS analysis and cardioprotective potential of Cucumis callosus on doxorubicin induced cardiotoxicity in rats. Int J Pharm Pharm Sci 8:239–45. https://doi.org/10.22159/ijpps.2016.v8i9.13292
Veena RK, Ajith TA, Janardhanan KK (2018) Lingzhi or reishi medicinal mushroom, Ganoderma lucidum (Agaricomycetes), prevents doxorubicin-induced cardiotoxicity in rats. Int J Med Mushrooms. https://doi.org/10.1615/IntJMedMushrooms.2018027010
Wu YZ, Zhang L, Wu ZX, Shan TT, Xiong C (2019) Berberine ameliorates doxorubicin-induced cardiotoxicity via a SIRT1/p66Shc-mediated pathway. Oxid Med Cell Longev 2019:2150394. https://doi.org/10.1155/2019/2150394
Xu F, Li X, Xiao X, Liu LF, Zhang L, Lin PP, Zhang SL, Li QS (2017) Effects of Ganoderma lucidum polysaccharides against doxorubicin-induced cardiotoxicity. Biomed Pharmacother 95:504–512. https://doi.org/10.1016/j.biopha.2017.08.118
Xu J, Zhang B, Chu Z, Jiang F, Han J (2021) Wogonin alleviates cisplatin-induced cardiotoxicity in mice via inhibiting gasdermin D-mediated pyroptosis. J Cardiovasc Pharmacol 78(4):597–603. https://doi.org/10.1097/FJC.0000000000001085
Yavas G (2022) Mechanisms of radiation-induced cardiovascular complications. Turk J Oncol 37(2):1–12. https://doi.org/10.5505/tjo.2022.S1002
Ye B, Ling W, Wang Y, Jaisi A, Olatunji OJ (2022) Protective effects of chrysin against cyclophosphamide-induced cardiotoxicity in rats: a biochemical and histopathological approach. Chem Biodivers 3:e202100886. https://doi.org/10.1002/cbdv.202100886
Yim TK, Wu W, Pak W, Ko KM (2001) Hepatoprotective action of an oleanolic acid-enriched extract of Ligustrum lucidum fruits is mediated through an enhancement on hepatic glutathione regeneration capacity in mice. Phytother Res 15:589–592. https://doi.org/10.1002/ptr.878
Younis NS (2020) Doxorubicin-induced cardiac abnormalities in rats: attenuation via sandalwood oil. Pharmacology 105(9–10):522–530. https://doi.org/10.1159/000504372
Yu X, Ruan Y, Huang X, Dou L, Lan M, Cui J, Shen T (2020) Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes. Biochem Biophys Res Commun 523(1):140–146. https://doi.org/10.1016/j.bbrc.2019.12.027
Yuen JW, Gohel MDI (2005) Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer 53:11–17. https://doi.org/10.1207/s15327914nc5301_2
Zahin M, Aqil F, Husain FM, Ahmad I (2013) Antioxidant capacity and antimutagenic potential of Murraya koenigii. Biomed Res Int. https://doi.org/10.1155/2013/263509
Zhang N, Shou B, Chen L, Lai X, Luo Y, Meng X, Liu R (2020a) Cardioprotective effects of latifolin against doxorubicin-induced cardiotoxicity by macrophage polarization in mice. J Cardiovasc Pharmacol 75(6):564–572. https://doi.org/10.1097/FJC.0000000000000827
Zhang X, Hu C, Kong CY, Song P, Wu HM, Xu SC, Yuan YP, Deng W, Ma ZG, Tang QZ (2020b) FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ 27:540–555. https://doi.org/10.1038/s41418-019-0372-z
Zou L, Liao M, Zhen Y, Zhu S, Chen X, Zhang J, Hao Y, Liu B (2022) Autophagy and beyond: Unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications. Acta Pharm Sin B 12(10):3743–3782. https://doi.org/10.1016/j.apsb.2022.06.004
Acknowledgements
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Khairnar, S.I., Kulkarni, Y.A. & Singh, K. Cardiotoxicity linked to anticancer agents and cardioprotective strategy. Arch. Pharm. Res. 45, 704–730 (2022). https://doi.org/10.1007/s12272-022-01411-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-022-01411-4